Chargement en cours...
SAT-505 A Rare Case of Teriparatide Induced Persistent Hypercalcemia
INTRODUCTION Teriparatide is a recombinant endogenous parathyroid hormone. It is an anabolic medication which is FDA approved for treating Osteoporosis in postmenopausal women, men with primary or hypogonadal osteoporosis and Glucocorticoid-induced osteoporosis. Transient hypercalcemia with Teripara...
Enregistré dans:
| Publié dans: | J Endocr Soc |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Endocrine Society
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552103/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-505 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|